BioMarin Deutschland

BioMarin Deutschland

This company is committed to the communities it treats beyond the therapies.

HQ location
San Rafael, United States
Launch date
Market cap
$10.6b
Enterprise value
$9.9b
Share price
$54.97 BMRN
Company register number
HRB 95536 (Frankfurt am Main)
Recent deals
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
*

$1.0b

Post IPO Equity
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues0000000000000000000000000000
% growth9 %(1 %)14 %15 %18 %10 %10 %
EBITDA0000000000000000000000000000
% EBITDA margin-3 %8 %13 %22 %--
Profit0000000000000000000000000000
% profit margin46 %(3 %)7 %7 %15 %--
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue34 %34 %31 %31 %26 %--

Source: Company filings or news article, Equity research estimates

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by BioMarin Deutschland

Edit
Inozyme
ACQUISITION by BioMarin Deutschland May 2025